Virginia Retirement Systems’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$576K Buy
27,200
+17,100
+169% +$366K ﹤0.01% 922
2026
Q1
$221K Buy
+10,100
New +$225K ﹤0.01% 898
2025
Q4
Sell
-58,400
Closed -$684K 1001
2025
Q3
$684K Buy
58,400
+12,400
+27% +$123K ﹤0.01% 689
2025
Q2
$428K Buy
46,000
+26,100
+131% +$214K ﹤0.01% 784
2025
Q1
$134K Buy
+19,900
New +$191K ﹤0.01% 989

Other funds holding IMNM

Virginia Retirement Systems's IMNM Position: Q2 2026 in Review

Virginia Retirement Systems increased its Immunome (IMNM) stake by 169% in Q2 2026, buying an estimated $366K and bringing the position to 27,200 shares worth $576K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

Virginia Retirement Systems first reported a position in IMNM in Q1 2025 and has held it in 5 quarters since. The position peaked at $684K in Q3 2025. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Virginia Retirement Systems held 27,200 shares of Immunome worth $576K as of Q2 2026.
  • Virginia Retirement Systems bought 17,100 Immunome shares in Q2 2026, an estimated $366K.
  • Immunome made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #922 holding.
  • Virginia Retirement Systems first reported a position in Immunome in Q1 2025 and has held it in 5 quarters since.
  • Virginia Retirement Systems's Immunome position peaked at $684K in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.